Cocrystal Pharma, Inc.
NASDAQ: COCP0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Sam Lee
- Employees
- 11
- Headquarters
- Bothell, United States
- IPO year
- 2012
- Market cap
- $10.8M
- Website
- https://www.cocrystalpharma.com
Loading COCP…
Loading profile data…Frequently asked questions about COCP
What does Cocrystal Pharma, Inc. (COCP) do?
Cocrystal Pharma, Inc. (COCP) is a biotechnology firm dedicated to researching and advancing antiviral treatments for severe and/or persistent viral illnesses. The company leverages structure-based technologies to create new antiviral medications, primarily focusing on infections caused by the hepatitis C virus (HCV), influenza, coronaviruses, a...
Where does COCP trade?
Cocrystal Pharma, Inc. (COCP) trades on the NASDAQ Capital Market.
What sector is COCP in?
Cocrystal Pharma, Inc. (COCP) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Cocrystal Pharma, Inc.?
Sam Lee is the chief executive officer of Cocrystal Pharma, Inc. (COCP).
Where is Cocrystal Pharma, Inc. headquartered?
Cocrystal Pharma, Inc. is headquartered in United States.
Does COCP pay a dividend?
Cocrystal Pharma, Inc. (COCP) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did COCP go public?
Cocrystal Pharma, Inc. (COCP) completed its initial public offering in 2012.